Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.
about
The 2014–2015 Ebola outbreak in West Africa: Hands OnEbola virus disease and critical illness.Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic ReviewAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksExperimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialA response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responseExperimental Treatment of Ebola Virus Disease with Brincidofovir.Clinical Management of Ebola Virus Disease in the United States and EuropeViral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.Discovering Drugs for the Treatment of Ebola Virus.Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review.Clinical Management of Patients with Ebola Virus Disease in High-Resource Settings.Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences.Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.Treatment-focused Ebola trials, supportive care and future of filovirus care.
P2860
Q24049114-9150D454-7FC7-4568-ADD5-E85C20C4B9C6Q26250274-6116CECF-1C8D-495B-B44B-F60983D40330Q26765404-5A89D13D-1E5A-40F2-9FBC-571A42C8BF94Q26801423-7A6C46DD-1278-4734-B69A-42601A896F6CQ28551448-F236F2D9-6406-4DB0-8CFA-4E0F95EC3D9DQ30196960-16F19E00-2061-4F7E-840D-496C2A139E36Q36127815-E51A7455-5B8D-4DC2-BCC8-0EBCFAA522F9Q37149584-A56FB8A2-F42B-49C6-A1CD-548D9C3AE863Q38158967-C5134B8F-9B83-4B2D-8665-841E1B931077Q38665891-78113479-091A-4749-868D-7CF83DCC3ED6Q40039706-65F40556-B000-4A54-9FE6-0C6943116F56Q40045378-92E7A027-0B62-475A-B2C4-13CD438EE4FEQ40053102-0A186F86-C8E9-4156-BB67-9700C3DE1A69Q40092794-4646EE6F-95C2-427C-82DC-84D1FD4B773DQ40099285-3CA9D296-1B1A-4A29-A2E0-9EBB3CD80383Q40122905-9F0FE5CA-FB6A-45F0-BB52-7894CFBF7A52Q47360326-51DA8215-CED7-4F6D-ADD0-2456FFF08780
P2860
Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Administration of Brincidofovi ...... ient With Ebola Virus Disease.
@en
type
label
Administration of Brincidofovi ...... ient With Ebola Virus Disease.
@en
prefLabel
Administration of Brincidofovi ...... ient With Ebola Virus Disease.
@en
P2093
P2860
P356
P1476
Administration of Brincidofovi ...... ient With Ebola Virus Disease.
@en
P2093
Amy J Schuh
Andre C Kalil
Angela L Hewlett
Diana F Florescu
Philip W Smith
P2860
P304
P356
10.1093/CID/CIV395
P407
P577
2015-05-19T00:00:00Z